XYLOTIN 300 - Lidocaine Hydrochloride INJECTION USP 300MG/30ML
Product details
Registration number: SIN15953P
Classification: Prescription Only
Active ingredients: Lidocaine Hydrochloride
Strength: 300mg/30ml
Dosage form: INJECTION, SOLUTION
Route: INTRAVENOUS
Registrant: HETERO SINGAPORE PTE. LTD.
ATC code: N01BB02
HSA approval date: 12 June 2020
Manufacturer(s): Aspiro Pharma Limited
Manufacturing country/countries: INDIA
What are the HSA registration number and classification for XYLOTIN 300 - Lidocaine Hydrochloride INJECTION USP 300MG/30ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15953P
Classification: Prescription Only
What active ingredients and strength are recorded for XYLOTIN 300 - Lidocaine Hydrochloride INJECTION USP 300MG/30ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Lidocaine Hydrochloride
Strength: 300mg/30ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for XYLOTIN 300 - Lidocaine Hydrochloride INJECTION USP 300MG/30ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for XYLOTIN 300 - Lidocaine Hydrochloride INJECTION USP 300MG/30ML?
According to the HSA dataset updated 7 August 2026:
Registrant: HETERO SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for XYLOTIN 300 - Lidocaine Hydrochloride INJECTION USP 300MG/30ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Aspiro Pharma Limited
Manufacturing country/countries: INDIA
Where can I look up XYLOTIN 300 - Lidocaine Hydrochloride INJECTION USP 300MG/30ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15953P or the exact product name XYLOTIN 300 - Lidocaine Hydrochloride INJECTION USP 300MG/30ML. The general register link does not preselect this product.
What are the source dates for this XYLOTIN 300 - Lidocaine Hydrochloride INJECTION USP 300MG/30ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this XYLOTIN 300 - Lidocaine Hydrochloride INJECTION USP 300MG/30ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15953P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)